Rationale: Epigenetic changes are implicated in the persisting vascular effects of hyperglycemia. The precise mechanism whereby chromatin structure and subsequent gene expression are regulated by glucose in vascular endothelial cells remain to be fully defined.
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The molecular determinants that regulate and distinguish gene expression patterns in response to glucose in the endothelium are not well understood. An emerging picture is developing that chromatin modifications and epigenetic changes may be critical. 6 One of the most recent and striking biochemical observations is that exposure to glucose can selectively mediate chromatin modifications specifically on the histone H3 tail that are relevant to inflammatory gene expression. In particular, histone methylation has received considerable attention in recent years with the identification of lysine-specific methyltransferase enzymes and what has now become commonly referred to as the histone code. 11 The diversity of posttranslational modifications provides unique structural changes that are associated with distinguishable gene expression patterns. 12 For example, mono-methylation of histone H3 lysine 4 (H3K4m1) is an activating mark associated with increased gene expression. The methyl writing events mediated on lysine residues of histones are conferred by methyltransferases that contain a catalytic SET domain that is related to the yeast Set1 and the Drosophila Trx or MLL family. 13, 14 Set7 methyltransferase was originally characterized by isocratic fractionation with substrate preference for lysine. 15 Due to site specificities including structural and conformational restraints, the Set7 enzyme can catalyze H3K4m1, which has been well described in more recent experimental studies. 16 -19 However, Set7 cannot transfer a second or third methyl group because of the dependence on water channel formation and associative S-adenosylmethionine (AdoMet) cofactor. 20, 21 Despite these advances in our understanding of histone modification, the specific gene targets and the precise nature of regulation still remain poorly understood.
In this article, we specifically examine the role of glucose sensing on lysine methyltransferase in vascular cells, with the key objective to understand the biochemical properties of Set7. We hypothesize that Set7 regulates key genes important to vascular cell damage by H3K4m1-dependent and H3K4m1-independent mechanisms and discuss how we have identified distinguishable enzymatic activity of chromatin substrates from that of isolated nonnucleosomal-derived histones, thus showing for the first time the importance and specificity of glucose mediated mono-methylation on target genes. Furthermore, we examined the role of Set7 and determining persistent changes in chromatin structure and gene expression in response to transient exposure to hyperglycemia, thus providing additional evidence for chromatin modifications implicated in hyperglycemic memory.
Methods
An expanded Methods section is available in the Online Data Supplement.
Cell Culture
Human microvascular endothelial cell lines (HMEC-1) were cultured in MCDB131 medium supplemented with fetal bovine serum, L-glutamine, and antibiotics (Gibco).
Hyperglycemic Mice
Male C57Bl6 mice 8 weeks of age (nϭ6/group) were randomized to receive 4 sequential injections of glucose (3 g/kg IP) or an equivalent volume of 0.9% saline delivered 2 hours apart. This protocol produces a sustained elevation in plasma glucose levels (15-25 mmol/L) for 8 hours, after which time no difference in plasma glucose levels is detectable between treated and control mice.
Results

Biochemical Characterization and Mono-Nucleosomal Distinction of the Set7 Methyltransferase
To characterize the binding of Set7 with chromatin, we analyzed the determinant with the aid of 2 antibodies (antibody PJ, a kind gift from Dr P.L. Jones, Urbana, IL, and CST, a commercially available antibody from Cell Signaling Technology, Inc). Quantification by infrared imaging of the endogenous protein revealed that Set7 was detected in nonchromatinized fractions ( Figure 1A) . We examined the chromatin accessibility of Set7 by fractionating nuclei that were subjected to micrococcal nuclease (MNase) exposure for 1, 8, or 24 minutes. The S1 supernatant fraction commonly consists of mono-nucleosomal DNA, 22 whereas the S2 nucleosomal fractions are mainly depleted with transcribed DNA. 23 The insoluble precipitant pellet (ppt) represents long-heterogeneous DNA that is less accessible to nuclease digestion ( Figure 1B ). Endogenous Set7 existed in the soluble S1 mono-nucleosomal supernatant, which contained the least amount of DNA (Ͻ5% of the total DNA content, Figure 1B , bottom panel). Set7 coexisted with transcriptional coactivator proteins such as the histone acetyltransferase p300 and the SWI/SNF subunit, Brg1. Both of these coactivator proteins were identified in the S1 supernatant and were not significantly enriched in the ppt fraction. The majority of nucleosomal DNA existed in the S2 fraction indicating that the endogenous Set7 protein was specifically enriched on mononucleosomal DNA ( Figure 1B) .
We determined the size of the Set7-containing protein complexes using gel filtration chromatography. The Set7-containing complex varied from its monomeric position (nonchromatinized, upper panel) to a larger molecular weight complex (chromatinized, middle panel; Online Figure I ). Next, we examined interacting proteins and showed that the large subunit of the SWI/SNF complex, Brg1, can be associated with chromatinized Set7 ( Figure 1D ). We also examined the nuclear identity of the protein using classic stepwise salt extraction 24 and addressed the hypothesis that membrane permeability was critical for the proper biochemical extraction of Set7. The nuclear proteins LSD1, Brg1, Brm, and hnRNP1A were isolated under higher salt, whereas Set7 was specifically fractionated under low salt (0.01 mol/L KCl) conditions ( Figure 1C ). Taken together, the outlined experiments indicate that Set7 has a preference for mononucleosomes in human endothelial cells.
Analysis of Set7 Localization in the Endothelial Cell
To study the subcellular distribution of Set7 protein in detail, we sought to reproduce the inhibition of RNA polymerase II (RNA pol II) transcription. 25 Inhibitors such as cycloheximide (CHX) and actinomycin D (ActD) have been used to identify new shuttling proteins. The localization of exogenous (FLAG-tagged Set7 protein; FLAG-Set7) by immunofluores-cence microscopy indicated identical nucleocytoplasmic distribution to the endogenous Set7 protein (Online Figure II,  A) . The endothelial cells were exposed to CHX and ActD to assess Set7 immunofluorescent signals. Whole cell extracts prepared from cells treated with DMSO alone or in the presence of CHX or ActD showed no significant changes in total Set7 protein expression under these conditions ( Figure  2A ). The subcellular distribution of FLAG-Set7 protein and the endogenous SWI/SNF determinant, Brg1, was monitored by immunofluorescence microscopy. The FLAG M2 monoclonal antibody clearly distinguished the locality of Set7 protein in control cells (DMSO, Figure 2B ). Exposure to CHX (20 g/mL) significantly reduced Set7 immunofluorescent signal in the nucleus (CHX, Figure 2B ), whereas the cells exposed to ActD (1 g/mL) exhibited increased FLAGSet7 signal in the nucleus (ActD, Figure 2B and Online Figure II, A) . We quantified the nuclear FLAG-Set7 signals in more than 100 cells, using image analyzing software. Increased Set7 signal was detected in the nucleus after ActD exposure, whereas it was reduced after CHX treatment ( Figure 2C ). Interestingly, Set7 was also observed on chromosomes during metaphase and telophase, with strong alignment of staining for FLAG-Set7 signals on the metaphase plate (Online Figure III) . These results suggest that Set7 is dynamically associated with chromatin and is not restricted nor confined to the cytoplasm.
Endothelial Set7 Distinguishes Nonnucleosomal Histones
It appears that the Set7 methyltransferase mediates H3K4m1 on core and mono-nucleosomes, and we anticipated that we could distinguish the methyl writing capabilities by analyzing histone methylation from wild-type (wt) and Set7 knock-down (Set7KD) cells. We could discriminate specific changes in H3K4m1 by 0.52 mol/L KCl extracted histones, which were distinguishable from acid extracted total histones (Online Figure IV, A) . These results argue against oligonucleosomes as the preferred substrate for the Set7 enzyme. To address this hypothesis, we fractionated S1, S2, and ppt extracts as well as core histones, using low salt extraction conditions (Online Figure IV, B) . Mono-methylation of H3K4 in Set7KD cells was unchanged in chromatin preparations isolated from the soluble S1 fraction (which is typically mononucleosomal), the second soluble supernatant S2 fraction (oligonucleosomes), and the ppt fraction (heterogeneous nucleosomal ladder, see Online Figure IV , B, and Figure  3A) . In striking contrast, H3K4m1 levels were significantly reduced from extractable core histones prepared from low salt preparations in Set7KD cells ( Figure 3A and 3B). We also confirmed that H3K4m3 and H3K9m3 levels were unchanged between wild-type and Set7KD cells (Online Figure IV, C) , which is consistent with recent reports. 7 The second approach to determine the methyl writing ability of the Set7 enzyme was to measure histone methyltransferase activity of the Set7 in chromatin fractions ( Figure 3C ). We immunopurified FLAG-Set7 from each chromatin fraction by using the anti-FLAG M2 monoclonal antibody. The results showed that immunopurified Set7 enzyme prepared from low salt extracts have significant methyltransferase activity using synthesized H3K4 peptide as the substrate (Online Figure V, A) . To determine whether H3K4 is a unique methylation site for Set7 methyltransferase activity, we also tested the H3R4 peptide (mutation of lysine for arginine residue), which eliminated the ability of the peptide to serve as a substrate for purified Set7 methyltransferase ( Figure 3C ). H3K4 methylation was detectable although significantly reduced (20 g ) was analyzed by immunoblot using anti-Set7 and GAPDH antibodies. GAPDH was used as a loading control. B, Effect of transcriptional inhibition on the subcellular locality of the Set7 methyltransferase. Human endothelial cells were incubated alone (DMSO, left panel) or in the presence of CHX (middle panel) or ActD (right panel). Fluorescence microscopy identifies nuclear retention of Set7 protein by anti-FLAG M2 monoclonal antibody (red signal) in the cells overexpressing FLAG-Set7. Anti-Brg1 polyclonal antibody (green signal) and nDNA content was stained using DAPI (blue signal). Magnification 100ϫ for images. C, Quantification of nuclear Set7 signals in human endothelial cells overexpressing FLAGSet7 incubated alone (DMSO for 6 hours) or in the presence of CHX treated for 0.5 hours or 3 hours or Act D treated for 6 hours. The quantification of FLAG-Set7 signals in more than 100 cells was performed with the use of Metamorph software (Universal Imaging Co). ***PϽ0.0001. Figure 3 . Purification of distinct nucleosomal and nonchromatinized Set7 protein isolated from human endothelial cells indicates specific H3K4 methyltransferase activity. A, Knockdown (KD) of the Set7 methyltransferase indicated that H3K4m1 was specifically reduced in low salt extracts compared with unremarkable changes in S1, S2, and ppt-chromatin fractions (wt indicates wild-type) (arrow). Immunoblots were performed to chromatin fractions using anti-Set7, H3K4m1, H3K4m3, H3K9m3, total Histone H3, and GAPDH antibodies. B, Quantification of H3K4m1 and H3K4m3 levels in low salt extracts validated by an infrared imaging system. Total Histone H3 was shown as an equal loading. Samples were analyzed in triplicate (nϭ3). *PϽ0.05. C, H3K4 methyltransferase activity was distinguished between nucleosomal (S1, S2, and ppt fractions) and nonchromatinized (low salt) protein extracts, indicating that the substrate Set7 preferred nonnucleosomal H3. Substrates used to determine methyltransferase activity were synthesized histone H3K4 and mutant H3R4 peptides. Samples were analyzed in triplicate (nϭ3).
in the S1 (mono-nucleosomes) and S2 (oligonucleosomes) nuclear fractions (Online Figure V, B) . These results indicate that Set7-associated histone methyltransferase activity exists in core or nonnucleosomal low salt extracts.
High Glucose Promotes Set7 Nuclear Localization in Human Endothelial Cells
We next examined the impact of high glucose (HG) conditions on Set7 localization and its consequence on proinflammatory gene expression. To exclude the possibility that glucose alters Set7 protein levels, we determined total Set7 protein expression by immunoblotting. Increasing D-glucose to 30 mmol/L did not alter Set7 expression ( Figure 4A ). We analyzed the chromatinized and nonchromatinized association of Set7 in response to hyperglycemia. The results showed that elevated glucose levels (15 and 30 mmol/L) increased endogenous Set7 association in soluble chromatinized fractions ( Figure 4B ). Next, we determined the close correspondence of HG with the subcellular locality of Set7, using immunofluorescence microscopy and quantification of FLAG-Set7 signals in the nucleus. Endothelial cells were exposed to elevated D-glucose (5, 15, or 30 mmol/L) for 16 hours ( Figure 4C ). These results indicate that glucose increases the Set7 protein signal in the nucleus ( Figure 4D 
Activation of Proinflammatory Genes by High Glucose Is Dependent on Set7 But Distinguished by H3K4m1 Gene Patterns
Because hyperglycemia is thought to regulate an unknown number of genes, we profiled gene expression in human endothelial cells. We used Illumina 6WG microarrays and identified differentially expressed genes by massive parallel sequencing, using Illumina GAIIx with a threshold change of Ͼ1.3 after knockdown of the Set7 methyltransferase (Online Table II ). Gene-ontology analysis of cells exposed to HG identified downregulation of genes involved in cell proliferation and cytokine activity (Online Table III , A) and upregulation of genes involved in blood circulation and angiogenesis in the Set7KD cells (Online Table III, B) . In endothelial cells, several major proinflammatory genes, such as HMOX1, ICAM1, IL-6, and IL-8, as well as ET-1, are upregulated by hyperglycemia; however, the molecular determinants that regulate expression are as yet unknown. 26 -29 To determine the role of Set7 in the regulation of proinflammatory genes, we examined the expression of these genes in Set7KD and overexpressed FLAG-Set7 cells ( Figure 5A and 5B). HMOX1 gene expression was increased, whereas ICAM-1 If high glucose promotes the activation of proinflammatory genes, we predicted that knockdown of Set7 would not sustain these gene-activating events. To test this hypothesis, we examined 2 glucose-inducible genes, IL-8 and HMOX1. These genes were inversely dependent on Set7 for their expression (Online Table II ). Whereas IL-8 was clearly downregulated by knockdown of the Set7 methyltransferase, HMOX1 was upregulated in Set7KD cells. Indeed, we determined that hyperglycemia (30 mmol/L) increased gene expression of both IL-8 and HMOX1 ( Figure 5C , nontarget control, gray bars). As predicted, based on Set7 playing a key role with gene expression, hyperglycemia did not elevate IL-8 and HMOX1 gene expression in Set7KD cells ( Figure 5C , open bars). This is consistent with Set7-mediated gene expression in response to hyperglycemia. To determine if gene expression was associated with H3K4m1, we performed promoter walk chromatin immunoprecipitation (ChIP) assays for the upstream region of the transcription start site for the IL-8 and HMOX1 genes ( Figure 6A ). High glucose clearly increased H3K4m1 in all regions (R1-R4) of the IL-8 gene, indicating that expression is dependent on mono-methylation of H3K4 by the Set7 enzyme ( Figure 6B ). Interestingly mono-methylation of H3K4 remained unchanged on the HMOX1 genes in nontarget and Set7KD cells in response to hyperglycemia ( Figure 6C ).
Persistent Activation of Proinflammatory Genes Is Associated With H3K4m1 in an Animal Model of Hyperglycemic Memory
We have shown that Set7 protein plays a critical role in sensing hyperglycemia and induces inflammatory responses in human endothelial cells in a H3K4m1-dependent and H3K4m1-independent manner. To determine the role of H3K4m1-mediated transcriptional changes in an animal model, C57Bl56 mice were injected with glucose, achieving plasma levels at 15 to 25 mmol/L over 8 hours, after which time no difference in plasma glucose levels is detectable between treated and control mice. Mice were monitored at 1 or 7 days (Figure 7A) , euthanized, and the aortae were isolated. Prepared whole cell extracts were immunoblotted with anti-Set7 and anti-GAPDH antibodies, confirming that hyperglycemia does not change overall Set7 protein expression ( Figure 7B ). Gene expression of CXCL-2 (mouse IL-8 homologue) and HMOX-1 were increased in the aortae of mice after the onset of transient hyperglycemia when compared with saline control animals ( Figure 7C and 7D) . Mice intraperitoneally injected with glucose to result in transient hyperglycemia (20 -30 mmol/L) for 8 hours also demonstrated persistent expression of HMOX-1 and CXCL-2 in their aortae when compared with saline injected mice that was detectable 1 day or 1 week after exposure to glucose ( Figure 7C and 7D) . Next, we determined whether this increase in gene expression was associated with H3K4m1 modification. Consistent with our hypothesis that IL8 is dependent on H3K4m1 mark written by the Set7 enzyme in human endothelial cells, ChIP assays clearly show increased H3K4m1 on the CXCL2 promoter and this modification had persisted for 7 days after the original glucose stimulus in the mouse aorta ( Figure 7E ). HMOX-1 gene expression conferred by hyperglycemia was also independent of H3K4m1 in the model of glycemic memory ( Figure 7F ). Because the Set7 methyltransferase does not catalyze dimethylation or trimethylation, we tested our hypothesis that H3K4m1 is specifically enriched on promoters in response to high glucose. The results indicate no significant difference of H3K4m3 enrichment on the CXCL-2 and HMOX-1 genes, respectively ( Figure 7G and 7H ). Taken together with the in vitro data, the experimental results of the in vivo memory experiments suggest that hyperglycemia activates Set7-mediated gene expression and that the IL-8 (CXCL-2) and HMOX1 genes are indeed distinguished by H3K4m1 (Figure 8 ).
Discussion
Despite the clear importance of glucose control in the development and progression of vascular complications of diabetes, the specific molecular events initiating pathophysiological changes in response to hyperglycemia remain poorly understood. In this series of experiments, we demonstrate that exposure of endothelial cells to hyperglycemia activates the expression of key proinflammatory genes due the mobilization and nuclear actions of the Set7 methyltransferase. Some of this effect is mediated by H3K4m1 writing events, such as the induction of IL-8. By contrast, glucose and Set7-mediated induction of HMOX1 expression appears to be independent of H3K4m1. These findings identify Set7 as a key mediator of diabetic vascular pathology and a potential target for vasculoprotective therapy.
The present studies were primarily performed in endothelial cells, which are thought to be the vulnerable target of hyperglycemic damage because glucose uptake is concentration-dependent rather than mediated by insulin. 30, 31 However, other cells types may also be affected by glucose via similar mechanisms. Recent reports have identified extensive interactions between the Set7 methyltransferase with NFB-dependent gene activity in monocytes, 9 glucose responsive genes in pancreatic islets with distinct regulatory functions, 32 and the lysine methylation of NFB-p65 in response to cytokines. 33 Indeed, the Set7 protein can mediate the methylation of histones as reflected by its role in H3K4 15, 19, 34 as well as nonhistone proteins 35 and is critical for transcriptional control of such proteins including TAF10, p53, and ER␣. 36 -38 These studies have emphasized the multiplicity of protein substrates that not only modify histones but also the lysine residue of nonhistone proteins.
The results presented here suggest that the human IL-8 gene and its mouse homologue are dependent on H3K4m1 writing events, whereas Set7-mediated expression of the HMOX1 gene is independent of mono-methylation of H3K4. These findings show for the first time that H3K4m1 distinguishes gene-activating events conferred by hyperglycemia that are associated with the Set7 methyltransferase on different genes implicated in vascular injury. Furthermore, recent primary findings have demonstrated other chromatin modifications, namely, histone hyperacetylation and genomic methylation, are also mediated by hyperglycemia. 39 As with H3K4m1 mediated by Set7, the activity of core chromatin modifying components such as acetyltransferases 40 or DNA methyltransferases 41 may function downstream of Set7 to integrate signals such as hyperglycemia to target specific genes, such as HMOX1.
Chromatin accessibility analyses revealed some unanticipated results relevant to our understanding of proinflammatory gene expression in response to elevated glucose. Rather than a reduction in H3K4m1, we observed comparable Set7 association in soluble chromatin preparations enriched for S1, S2, and pellet fractions. Although initially considered surprising findings, these experimental results are in agreement with 
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observed changes between acid-and salt-extractable histones. Indeed, this latter result is as expected, because salt extraction of nonchromatinized histones clearly indicates reduced H3K4m1 from Set7KD cells. The evidence for this came partly from H3K4 methyltransferase activity experiments showing that the preferred substrate was nonnucleosomal H3.
In this context, and, consistent with these results, there is no exclusivity of Set7 with assembled chromatin and nucleosomal H3K4 methylation. These experiments alone do not prove that Set7 does not mediate mono-methylation of lysine 4 of H3 histones of soluble and insoluble chromatin. Instead, these experiments suggest a contextual distinction for Set7 association with chromatin in response to elevated glucose that has not been described previously. 42 Although our studies clearly link Set7 with glucose-dependent H3K4m1, other studies have suggested that the knock-down of Set7 by siRNA transfection does not reduce H3K4m1. 33 This disparity could reflect differences in cell types, although this discordance is more likely to reflect differences in the protocols used in the preparation and isolation of histones. In fact, this result is compatible with our extended biochemical investigations using salt and acid extractions. 43 We have shown that H3K4 mono-methylation is distinguishable from separated histones (nonchromatinized and free-unincorporated histones) using salt extraction.
In our experiments, exposure to high glucose induced translocation of Set7 into the nucleus and subsequent histone methylation/gene activating events. The Set7 protein does not contain nuclear localization sequences, which are character- Gene expression was normalized against saline treated mice using 3 aortas/group (nϭ3). E through H, Profiles of H3K4 methylation on the mouse CXCL2 (E and G) and HMOX1 (F and H) genes performed by chromatin immunopurification assays. Soluble chromatin was isolated from the aortas of hyperglycemic (solid bars) and salinetreated (open bars) mice and immunopurified with the anti-H3K4m1 (E and F) or anti-H3K4m3 (G and H) antibodies. Three independent ChIP experiments were performed, using 3 aortas/group (nϭ3). Quantitative PCR was used to measure the level of enrichment. The levels were normalized with the aortas from saline treated mice. *PϽ0.05, **PϽ0.005, ***PϽ0.0001. ized by short stretches of basic amino acids that are associated with nuclear trafficking. 44 Our view of nuclear protein import is derived mainly from RNA and protein molecules such as small nuclear RNAs and ribosomal proteins that traffic in one direction. 45 We showed increased nuclear Set7 after actinomycin D exposure, and this correlated with nuclear retention. Studies have shown that nucleocytoplasmic shuttling proteins alter their locality when cells are exposed to inhibitors of RNA pol II transcription and protein translation. 46 Thus, we hypothesize that the observed change in the Set7 signal correlates with import into the nucleus in response to transcriptional inhibition. In contrast, Set7 can passively diffuse out after CHX treatment because the protein size is less than 50 kDa. Interestingly, the subcellular localization of Set7 is altered in response to elevated glucose and this is associated with gene-activating changes.
Histone methylation patterns are widely regarded to be dynamically regulated, written, and erased by methylase and demethylase enzymes with target and amino acid specificity. However, persistent chromatin modifications and epigenetic changes have the potential to influence gene expression long after exposure to a modifying stimulus as an adaptive regulatory process. In our experiments, exposure of mice to transient hyperglycemia resulted in the induction of proinflammatory genes. Moreover, 1 week after a return to normal glucose homeostasis, these changes were maintained and associated with H3K4m1. In theory, the persistent activation of pathogenic pathways after transient glucose exposure via persistent chromatin modifications may contribute to the development of cardiovascular disease in prediabetic individuals and potentially the clinical phenomenon of hyperglycemic memory. 4 In conclusion, we show distinguishable changes in H3K4m1-mediated by hyperglycemia, using human in vitro studies and an in vivo mouse model of memory. We propose that the transcriptional mechanism involved in gene regulation mediated by glucose is dependent on the Set7 methyltransferase showing a clear distinction with H3K4m1 on target genes, indicating the importance of this enzyme in regulating key genes and proteins important in the vasculature. Further studies could expand the role of Set7 and examine the phenotype of inducible, endothelial-specific deletion in a diabetic mouse model, whereas its implication as a hyperglycemic sensor could represent a major therapeutic strategy to optimize end-organ protection in the complications of diabetes.
Novelty and Significance
What Is Known?
• Transient hyperglycemia is associated with proinflammatory gene expression.
• This expression has been attributed to Set7 methyltransferase in models of hyperglycemic persistence.
• Gene-activating hyperglycemia is associated with histone modification.
What New Information Does This Article Contribute?
• Set7 acts as hyperglycemic sensor and associated with distinguishable histone and nonhistone gene-regulatory events.
• Hyperglycemia promotes dynamic Set7 nuclear accumulation with specific nucleosomal preferences in vascular endothelial cells.
• This emphasizes intracellular glucose metabolism conferring geneactivating chromatin modifications associated with the legacy of hyperglycemia.
The relative importance of histone modifications has been associated with gene-activating epigenetic changes in distinct models of diabetes. Like most histone methyltransferase enzymes, the precise molecular mode signaling the specific modification of lysine residues by high glucose remains unclear and even misunderstood. The legacy of hyperglycemia can be distinguished by direct and indirect modifying events regulating identifiable gene targets. The emerging picture is that the Set7 methyltransferase enzyme is a critical hyperglycemic sensor modifying vascular gene expression and hence, a potentially novel therapeutic target of atherosclerosis and other diabetic vascular complications. Cell culture HMEC-1 cells overexpressing Flag-Set7 were created by retrovirus-mediated gene transfer as described previously.
1, 2 The knock-down of Set7 was performed in HMEC-1 cells by MISSION shRNA expressing lentivirus vectors (Sigma) as described previously. 1 The sequence targeting Set7 knockdown corresponds to 5'-CCAGATCCTTATGAATCAGAA-3' (TRCN0000078630). The cells transduced MISSION Non-target shRNA control vector (Sigma) were used as controls. The overexpression and knock-down of Set7 in the endothelial cells were verified by qRT-PCR and immunoblots using anti-Flag M2 monoclonal antibody (F1804, Sigma) and anti-Set7 rabbit serum (gift from Dr P.L. Jones, University of Illinois, USA) or anti-Set7 antibody (#2813, Cell Signalling Technology, Inc.). For hyperglycemia and osmolarity experiments, the cells were incubated with the medium with 1% FBS containing either 5, 15, 30 or 50mM D-glucose or similar concentrations of D-mannitol for 16 hours. Actinomycin D was used at 1µg/ml and cycloheximide was used at 20 µg/ml.
Biochemical characterisation analysis of Set7
Whole cell extract preparation, stepwise salt extraction, chromatin fractionation and histone extraction were performed as described previously. 3, 4 Low (non-chromatin) and high (chromatin-associated) salt extracts were prepared using 1 × 10 7 cells, washed twice with ice-cold PBS and lysed with the hypotonic buffer. After 10min at 4 ˚C, the low salt extract (supernatant) and the pellet was separated by centrifuge at 600 g for 5 min. The pellet was extracted with buffer C (20mM Hepes KOH, pH7.9, 25% Glycerol, 520mM KCl, 5mM MgCl 2 , 0.1mM EDTA, 1mM DTT, 0.5mM PMSF, 0.2% NP-40 and proteinase inhibitor (PI)) for 15 min at 4 ˚C. High salt extract was recovered fractionated by centrifuge at 15000 g for 15 min. Non-chromatin and chromatin-associated extracts were fractionated by FPLC on a Superdex 200 high-performance 10/300 column as described previously. 5 Stepwise salt extraction of HMEC-1 cells was performed as described previously 6 with hypotonic buffers containing 0.01, 0.05, 0.15, 0.25, 0.35, 0.45 or 1.5 M KCl with PI. For immunoprecipitation of FLAG-Set7, cell lysates were prepared from the cells expressing FLAG-Set7 or the cells transduced with pCX4neo as a negative control. 1 × 10 7 cells were washed twice with ice-cold PBS and extracted with 600 µl of lysis buffer (50mM Tris HCl, pH7.5, 150mM NaCl, 1mM EDTA, 1% Triton X-100 and PI). Lysates were incubated with anti-FLAG M2 affinity gel (Sigma) for 2 hours at 4 ˚C. Immunoprecipitates were washed with TBS three times and then eluted from the gels with 3X FLAG peptide (Sigma) and analyzed by immunoblots and histone methyltransferase activity assay. Histone methyltransferase activity assay were performed as described previously. 
Immunoblot analysis
Protein extracts and immunoprecipitates were analyzed by SDS-PAGE and immunoblots using antibodies against Brg1, BAF57, BAF155 (a kind gift from Dr S. Sif, The Ohio State University, USA), LSD1 (ab17721, Abcam), GAPDH (ab9484, Abcam), p300 (ab3164, Abcam), H3K4m1 (ab8895, Abcam; #39297, Active Motif; #07-436, Upstate), H3K4m2 (ab7766, Abcam), H3K4m3 (ab8580, Abcam), H3K9m3 (ab8898, Abcam), total Histone H3 (ab1791, Abcam), HP1 (#05-689, upstate), c-jun (#06-225, Upstate), CREB (#06-863, Upstate), hnRNP1A (R4528, Sigma), Suv39h1 (S8316, Sigma), TFIID, PKC (Santa Cruz), Brm (#610390, BD). Protein blotting signals were quantified by an infrared imaging system (Odyssey; LI-COR).
Immunofluorescence analysis HMEC-1 cell clones overexpressing FLAG-Set7 were fixed in 4% freshly prepared formaldehyde in PBS for 10 min at room temperature, and then permeabilized with 0.1% Triton X-100 in PBS for 5 min at room temperature. The cells were incubated with blocking buffer (1% goat serum in PBS), and then with anti-FLAG M2 antibody and anti-BrgI rabbit antibody mixture in blocking buffer for 1 hour at room temperature. Alexa488-linked anti-rabbit IgG and Alexa594-linked anti mouse IgG antibodies were used for detection. The cellular DNA was labelled with DAPI. Samples were observed on an Olympus microscope and images acquired with F-View II (Soft Imaging System). The quantification of nuclear FLAG-Set7 signal was performed by assessing the nuclear compartment from DAPI stained images and the average row signal intensity of FLAG-Set7 and Brg1 in the nucleus was calculated using Metamorph software (Universal Imaging Co.). The ratio of the nuclear FLAG-Set7 signal was normalized to nuclear Brg1 signal intensity as a stable chromatin protein control. The basal background ratio was calculated for each experiment as the nuclear FLAG-Set7 signal in the cells transduced with the control retrovirus pCX4neo vector (0.38 ± 0.05). The nucleus size was also measured by Metamorph software. More than 100 cells (n>100) were analysed and the data are presented as means ± SE.
RNA analysis
RNA isolation and gene expression analysis were performed as described previously.
1 Total RNA from the cells was extracted using Trizol reagent (Invitrogen) and the RNeasy Mini column (QIAGEN), and the RNA was reverse transcribed with the SuperScript III First Strand Synthesis System (Invitrogen). Reverse transcription PCR (qRT-PCR) was performed using ABI Prism 7500. The specific primers are described in the Online Table I .
Microarray hybridization and RNA-Seq analysis using massive parallel sequencing Microarray hybridization was performed on Illumina human 6WG arrays and arrays were analysed as described previously. 7 RNA-Seq libraries were prepared and sequencing was conducted on the Illumina Genome Analyzer (GAIIx) according to the manufacturer's instructions. The resulting sequencing reads were quantile normalized and 8,370 genes were filtered for significant detection confidence in at least 3 samples (single group) between non-target and Set7KD cells. Differentially expressed genes were identified using a combined Mann-Whitney significance filter of p<0.05 after applying a Benjamini-Hochberg method for false discovery rate and a threshold of 1.3 fold. Gene-ontology analysis was performed using DAVID Bioinformatics Resources 6.7 website (http://david.abcc.ncifcrf.gov/).
Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed as described previously using anti-H3K4m1 (abcam) and anti-H3K4m3 antibodies (Active Motif).
1 Cells and diced aortas were washed with PBS and cross-linked using 1% formaldehyde for 10 min followed by quenching with 0.1 M glycine for 10 min. Cell pellets and aortas were resuspended in SDS lysis buffer containing 1% SDS, 10mM EDTA, 50mM Tris-HCl, pH 8.0 and protease inhibitor cocktail (Roche). The aorta was then homogenized with the homogenizer (Pro Scientific Inc.) for 10 seconds 3 times. Cell lysates and tissue homogenates were sonicated to shear chromatin to 200-500 bp in length. Soluble chromatin immunoprecipitations were performed in shared chromatin diluted 10 times in ChIP dilution buffer containing 0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.0, 167 mM NaCl, and protease inhibitor cocktail and incubated with the antibodies or preimmune rabbit IgG for 2 hours at 4°C. Protein A magnetic beads (Dynabeads, Invitrogen) were added to capture the specific antibody-chromatin complex. After the incubation, the beads were subsequently washed and then incubated in the presence of Proteinase K for 2 h at 62°C to reverse the formaldehyde cross-linking. Antibody bound DNA fragments and input DNA samples were recovered and purified by NucleoSpin Extract II (MachereyNagel). Analysis of ChIP DNA samples was performed by quantitative PCR (qPCR) of the specific promoter regions described in the Online Table I . qPCR values were normalized to input DNA and to the values obtained with normal rabbit IgG.
Hyperglycemic mice
Mice are then followed for 1-day or 7-days, after which time they are killed with a lethal overdose of sodium pentobarbital followed by cardiac exsanguination. The aortas are isolated and cleaned, then snap frozen in Trizol (for gene expression analysis) or phosphate buffered saline (for ChIP analysis). All procedures were performed with approval of the Baker IDI animal ethics committee in accordance with National Health and Medical Research Council standards.
Statistical analysis
Statistical analysis was performed in GraphPad Prism 5.0 (GraphPad Software, San Diego, CA). Statistical significance was evaluated by Student's t test. A P-value less than 0.05 was considered significant. Error bars on all figures are represented as a standard deviation of the mean, unless otherwise stated. Immunofluorescence microscopy identifies nuclear accumulation of Set7 protein by anti-FLAG M2 antibody (red signal) in endothelial cells overexpressing FLAG-Set7. The chromatin determinant was recognized with an anti-Brg1 antibody (green signal) and nuclear DNA content was stained using DAPI (blue signal). Scale bars, 20µm. (B) Quantification of the nuclear Set7 signal in the endothelial cells overexpressing FLAG-Set7. The cells were incubated in 5 or 50 mM D-glucose medium for 16hrs. The rate of the FLAG-Set7 signal in the nucleus was calculated using Metamorph software (Universal Imaging Co.) and normalized to the BrgI signal intensity as a nuclear protein control. More than 100 cells (n>100) were analysed and the data are presented as means ± SE. ***P<0.0001
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